Letter to the Editior. Re Zhangqun Ye, Guohua Zeng, Huan Yang, et al. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Eur Urol 2018;73:385–91: Medical Expulsive Therapy for Distal Ureteral Stones: Call the Jury Back

Taimur T. Shah*, Graeme MacLennan, Rob Pickard, Samuel McClinton, Veeru Kasivisvanathan

*Corresponding author for this work

Research output: Contribution to journalLetter

1 Citation (Scopus)

Abstract

We read with interest the article by Ye et al [1] showing that tamsulosin therapy for stones in the distal ureter (DU) resulted in a higher spontaneous stone passage (SSP) than placebo (difference 7.8%, 95% confidence interval 5.2–10.4%), with a particular benefit for stones of 5–7 mm in size, with similar rates of adverse events in both arms. While meta-analyses of primarily small randomized trials showed a benefit of tamsulosin versus placebo [2], this was thrown into doubt when large, well-designed, randomized studies did not show this benefit [3], [4]. Differences in study design could explain the contrasting results from the published studies.
Original languageEnglish
Pages (from-to)e43-e44
Number of pages2
JournalEuropean Urology
Volume74
Issue number2
Early online date21 Mar 2018
DOIs
Publication statusPublished - 31 Aug 2018

Fingerprint Dive into the research topics of 'Letter to the Editior. Re Zhangqun Ye, Guohua Zeng, Huan Yang, et al. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Eur Urol 2018;73:385–91: Medical Expulsive Therapy for Distal Ureteral Stones: Call the Jury Back'. Together they form a unique fingerprint.

Cite this